Zymeworks Inc. (ZYME)

Zymeworks Inc. (ZYME) scores 50 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 1.96, representing a 93% premium to fair value. Quantitative score: 50/100. Qualitative score: 70/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full ZYME analysis on boothcheck